The European Institute for Biomedical Imaging Research (EIBIR) is dedicated to the coordination of research projects and aims to support the development of biomedical imaging technologies and the dissemination of knowledge.
We want to improve cooperation within the European biomedical imaging community, with the goal of improving the diagnosis, treatment and prevention of diseases. We actively support research networking activities and common initiatives and interoperability in the field of biomedical imaging research.
EIBIR was established on the initiative of The European Society of Radiology (ESR) in 2006 and funded by the European Commission within Framework Programme 6.
Our mission is to coordinate the development of biomedical imaging technologies in Europe and to support the dissemination of knowledge with the ultimate goal of improving diagnosis, treatment and prevention of disease.
We are proud to support more than 140 partners from 30 countries in their research
We help researchers navigate the rules and regulations of large EU-funded projects, so you can carry out innovative research.
European researchers are increasingly looking to EU funding sources to supplement or replace shrinking national research budgets. The multidisciplinary and multinational research consortia of these EU-funded research projects often require professional project management – it ensures the successful accomplishment of the project’s goals. By providing proposal preparation, project management and dissemination & communication services to researchers, we substantially increase your changes to acquire EU funding and aim to enhance biomedical imaging research, in Europe and beyond.
The majority of our efforts concern project management services for ongoing collaborative research projects, coordination of multi-centre clinical trials, and support during the preparation of project proposals under the European Commission’s Horizon 2020 framework. Our current research focus lies in radiology, molecular imaging and imaging biomarkers. The main target audiences include physicians, physicists, radiographers, chemists, mathematicians, molecular biologists, computer scientists.
Combining the expertise of our scientific advisory board, advice from our multi-disciplinary shareholder groups, input from ESR’s Research Committee and recommendations from the industry panel, EIBIR benefits from the guidance and support of a multi-faceted organisational structure that ensures EIBIR and biomedical imaging are at the forefront of research activities in Europe.
The Scientific Advisory Board sets and guides the organisation’s long-term strategies and goals for biomedical imaging research. It also provides invaluable expert advice and feedback to researchers on their proposals.
Prof. Regina Beets-Tan is EIBIR’s Scientific Director and leads the Scientific Advisory Board.
Our experienced team is highly motivated and knowledgeable in the preparation of proposals and the management and coordination of projects.
EIBIR’s shareholder organisations exemplify the importance of a multidisciplinary approach in biomedical imaging research. Their support is vital to EIBIR’s decision making. The shareholders are represented at the General Meeting, where major strategic decisions are taken and recommendations are developed for EIBIR’s other bodies and initiatives. Each shareholder organisation is also invited to nominate a representative to stand on EIBIR’s Scientific Advisory Board.
EIBIR gratefully acknowledges the support of its Industry Partners. Each partner can nominate one representative to sit on the EIBIR Industry Panel. The Industry Panel allows EIBIR and its member industry organisations to identify shared interests and opportunities for collaboration.
EIBIR is committed to promoting gender equality within our organisation. To accomplish this goal and to ensure the implementation of effective measures, we have drawn up a Gender Equality Plan.
